Successful management of severe allergic reactions to platelet transfusion with omalizumab: A case report.

Yeonjoo ChoiJa Min ByunInho KimJin Hyun ParkKi Hwan KimJin-Soo KimIn Sil ChoiMin-Suk YangHyunkyung Park

Published in: Medicine (2022)

This case suggests that omalizumab is a good candidate for the management of severe allergic transfusion reactions.